scispace - formally typeset
G

Guillaume Martin-Blondel

Researcher at University of Toulouse

Publications -  176
Citations -  3572

Guillaume Martin-Blondel is an academic researcher from University of Toulouse. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 24, co-authored 124 publications receiving 2228 citations. Previous affiliations of Guillaume Martin-Blondel include Paul Sabatier University & Ministère de la Défense.

Papers
More filters
Journal ArticleDOI

Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen?

TL;DR: This data indicates that high infectious viral load in semen of Ebola virus disease survivors may be a new sexually transmitted pathogen for the Zika virus, which has caused alarm in Latin America.
Journal ArticleDOI

Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study.

TL;DR: Patients with severe COVID-19 and without ischemic infarcts had a wide range of neurologic manifestations that were be associated with abnormal brain MRIs, and eight distinctive neuroradiological patterns were described.
Journal ArticleDOI

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.

Florence Ader, +163 more
TL;DR: The DisCoVeRy trial as mentioned in this paper evaluated the clinical efficacy of remdesivir plus standard care compared with standard of care alone in patients admitted to hospital with COVID-19, with indication of oxygen or ventilator support.
Journal ArticleDOI

Zika virus in semen and spermatozoa

TL;DR: The longitudinal follow up of Zika virus RNA in the semen of a 32-year-old man returning from French Guyana suggests that the length of Zikairus excretion varies, probably depending on viral and host characteristics, but long-lasting excretion might be frequent among adults who experienced a symptomatic infection.
Journal ArticleDOI

CCR5 blockade for neuroinflammatory diseases — beyond control of HIV

TL;DR: It is postulated that CCR5 antagonists, such as maraviroc, offer neuroprotective benefits in settings in which C CR5 promotes deleterious neuroinflammation, particularly in diseases in which CD8+ T cells seem to play a pivotal role.